apolipoprotein
risk
variant
known
result
risk
kidney
diseas
patient
african
ancestri
nephropathi
typic
occur
associ
certain
environment
factor
system
diseas
increas
evid
role
interferon
ifn
pathway
pathogenesi
collaps
glomerulopathi
patient
human
immunodefici
viru
hiv
infect
system
lupu
erythematosu
condit
associ
high
ifn
level
collaps
glomerulopathi
also
describ
patient
receiv
exogen
ifn
therapi
administ
variou
medic
condit
describ
patient
genet
condit
result
increas
ifn
state
stimul
ifn
gene
sting
associ
vasculopathi
onset
infanc
savi
develop
collaps
glomerulopathi
flare
diseas
patient
found
risk
variant
case
support
role
ifn
induc
collaps
glomerulopathi
apolipoprotein
also
known
trypanolyt
factor
human
serum
confer
protect
african
trypanosomiasi
two
commonli
occur
risk
variant
gene
result
signific
increas
risk
kidney
diseas
among
patient
recent
african
ancestri
renal
histopatholog
spectrum
associ
diseas
heterogen
includ
variou
pattern
diseas
includ
focal
segment
glomerulosclerosi
collaps
glomerulopathi
histolog
variant
focal
segment
glomerulosclerosi
nondiabet
kidney
failur
risk
variant
incomplet
penetr
patient
carri
highrisk
genotyp
never
develop
meaning
kidney
diseas
observ
along
frequent
identif
environment
factor
system
diseas
patient
diseas
suggest
possibl
scenario
commonli
associ
factor
includ
human
immunodefici
viru
hiv
infect
system
lupu
erythematosu
membran
glomerulopathi
addit
nephropathi
describ
patient
undergo
interferon
ifn
treatment
ifninduc
increas
podocyt
express
shown
vitro
stimul
interferon
gene
sting
associ
vasculopathi
onset
infanc
savi
type
interferonopathi
syndrom
first
describ
sting
critic
protein
type
ifn
respons
viral
doublestrand
dna
savi
gainoffunct
mutat
gene
encod
sting
caus
activ
boost
synthesi
type
ifn
type
ifn
trigger
posit
feedback
loop
lead
activ
janu
kinas
signal
transduc
activ
transcript
stat
stat
transcript
proinflammatori
ifnstimul
gene
clinic
savi
character
neonatalonset
system
inflamm
sever
cutan
vasculopathi
interstiti
lung
diseas
kidney
involv
associ
savi
previous
describ
present
case
collaps
glomerulopathi
patient
risk
allel
endogen
overproduct
type
ifn
secondari
savi
absenc
system
diseas
environment
factor
african
american
boy
one
fratern
twin
present
week
age
swell
digit
left
hand
subsequ
develop
multipl
recurr
skin
lesion
character
blister
progress
ulcer
skin
biopsi
perform
show
dermal
perivascular
interstiti
inflamm
vasculopathi
also
develop
recurr
ischem
chang
digit
toe
initi
laboratori
evalu
show
persist
elev
level
inflammatori
marker
unexplain
anemia
hemoglobin
gdl
subsequ
develop
thrombocytopenia
platelet
count
elev
ferritin
level
ngml
prolong
prothrombin
time
partial
thromboplastin
time
low
fibrinogen
level
gl
concern
macrophag
activ
syndrom
patient
initi
treat
highdos
corticosteroid
follow
slow
taper
dose
mgkg
daili
sildenafil
mg
per
day
partial
respons
continu
develop
skin
lesion
associ
high
fever
ischem
chang
digit
multipl
admiss
hospit
suspect
sepsi
immunocompromis
patient
also
failur
thrive
month
age
develop
respiratori
symptom
twice
admit
hospit
pneumonia
comput
tomographi
chest
show
diffus
parenchym
interstiti
abnorm
find
suggest
acut
chronic
inflamm
diagnosi
savi
made
age
month
target
genet
test
show
heterozyg
variant
predict
lead
valin
leucin
substitut
amino
acid
previous
report
savi
genet
test
famili
hemophagocyt
lymphohistiocytosi
hlh
period
fever
syndrom
defici
adenosin
deaminas
neg
base
find
patient
start
treatment
ruxolitinib
jak
inhibitor
mg
twice
daili
develop
new
skin
lesion
becam
less
frequent
well
frequenc
hospit
ruxolitinib
dose
increas
mg
patient
well
month
acut
episod
focal
seizur
time
magnet
reson
imag
brain
reveal
multipl
area
suggest
gliosi
superior
vermi
occipit
lobe
right
thalamu
prior
event
ischemia
howev
magnet
reson
angiographi
magnet
reson
venographi
result
normal
electroencephalogram
also
unremark
age
month
patient
admit
hospit
fever
poor
oral
intak
routin
immun
pediarix
glaxosmithklin
pneumococc
influenza
haemophilu
influenza
type
b
immun
ruxolitinib
treatment
hold
day
hospit
develop
blister
ulcer
site
immun
later
worsen
becam
diffus
also
worsen
digit
ischemia
lead
autoamput
workup
infect
includ
blood
cultur
urin
cultur
respiratori
polymeras
chain
reaction
panel
includ
influenza
parainfluenza
adenoviru
coronaviru
respiratori
syncyti
viru
rhinoviru
enteroviru
bordetella
pertussi
mycoplasma
pneumonia
serolog
test
cytomegaloviru
epsteinbarr
viru
parvoviru
workup
fail
show
infecti
caus
flare
develop
gener
edema
proteinuria
serum
albumin
level
gdl
consist
nephrot
syndrom
urinalysi
show
protein
proteincreatinin
ratio
mgmg
hospit
multipl
urinalys
perform
never
shown
proteinuria
also
develop
high
blood
pressur
treatment
mgkg
daili
enalapril
start
patient
treat
methylprednisolon
mgkg
daili
treatment
ruxolitinib
mg
twice
daili
restart
continu
nephroticrang
proteinuria
kidney
biopsi
perform
one
core
renal
cortex
avail
light
microscopi
contain
glomeruli
global
sclerot
nonsclerot
glomeruli
frequent
show
collaps
glomerular
tuft
associ
promin
epitheli
cell
hyperplasia
hypertrophi
fig
b
reactiv
epitheli
cell
show
numer
cytoplasm
protein
droplet
addit
focal
glomeruli
show
area
segment
glomerulosclerosi
otherwis
glomeruli
show
evid
mesangi
endocapillari
hypercellular
moder
interstiti
fibrosi
tubular
atrophi
present
involv
cortic
surfac
mild
mix
tubulointerstiti
inflamm
note
predominantli
within
area
scar
atroph
tubul
show
thyroid
pattern
atrophi
focal
microcyst
tubular
dilat
fig
nonatroph
tubul
show
mark
swell
tubular
epithelium
larg
number
cytoplasm
protein
resorpt
droplet
arteri
arteriol
unremark
six
glomeruli
avail
immunofluoresc
none
global
sclerot
stain
includ
immunoglobulin
iga
igg
igm
fibrinogen
light
chain
neg
within
glomeruli
stain
obtain
kent
laboratori
except
fibrinogen
light
chain
agil
igg
light
chain
proxim
tubul
protein
resorpt
droplet
stain
strongli
posit
ultrastructur
examin
glomerulu
use
electron
microscopi
show
uniform
glomerular
basement
membran
normal
thick
immun
electrondens
deposit
present
epitheli
foot
process
moder
effac
involv
avail
capillari
loop
endotheli
tubuloreticular
inclus
note
tubular
basement
membran
unremark
fig
f
two
glomeruli
examin
use
electron
microscopi
show
similar
degre
epitheli
footprocess
effac
dna
patient
peripher
blood
genotyp
risk
allel
use
taqman
primerprob
custom
design
assay
previous
describ
one
risk
variant
encod
serin
glycin
substitut
amino
acid
risk
variant
insertiondelet
encod
show
compound
heterozygos
case
patient
heterozyg
risk
allel
high
ifn
state
due
underli
condit
savi
provid
support
ifn
induc
collaps
glomerulopathi
individu
highrisk
genotyp
ifn
molecul
secret
respons
pathogen
product
result
inflammatori
state
patient
type
interferonopathi
affect
upregul
type
ifn
signal
persist
system
inflamm
grow
bodi
evid
implic
ifn
pathway
pathogenesi
collaps
glomerulopathi
collaps
glomerulopathi
fulmin
histopatholog
form
nephropathi
form
glomerulopathi
well
known
associ
diseas
increas
ifn
level
hiv
infect
system
lupu
erythematosu
addit
exogen
ifn
therapi
administ
variou
medic
condit
shown
associ
collaps
glomerulopathi
case
seri
patient
among
patient
test
homozyg
risk
variant
regardless
associ
condit
kidney
biopsi
patient
nephropathi
frequent
show
solidifi
disappearingtyp
glomerulosclerosi
thyroid
type
tubular
atrophi
microcyst
tubular
dilat
featur
evid
case
discuss
vitro
ifn
increas
express
pertin
overexpress
shown
injuri
cell
cell
cultur
anim
model
notabl
overexpress
risk
variant
injuri
cell
overexpress
wildtyp
protein
togeth
studi
demonstr
associ
increas
ifn
level
nephropathi
worth
note
although
present
case
highlight
potenti
ifn
caus
podocyt
injuri
sever
footprocess
effac
examin
glomeruli
discret
studi
patient
collaps
glomerulopathi
variou
clinic
set
shown
signific
variabl
degre
footprocess
effac
patient
absenc
sever
effac
electron
microscopi
report
case
nephropathi
set
genet
diseas
savi
type
interferonopathi
syndrom
rais
possibl
increas
risk
kidney
diseas
african
american
patient
diseas
addit
case
establish
pathogen
role
ifn
patient
risk
allel
similar
patient
exogen
ifn
therapi
patient
condit
lead
increas
endogen
ifn
level
develop
fulmin
form
nephropathi
collaps
glomerulopathi
